Why the study?
Does Hypericum hircinum extract prevent doxorubicin-induced cardiotoxicity in Wistar rats?
Does Hypericum hircinum extract prevent doxorubicin-induced cardiotoxicity in Wistar rats?
Hypericum hircinum extract demonstrates potential in preventing doxorubicin-induced cardiotoxicity in a rat model by reducing oxidative stress and cardiac marker enzymes.
Answers are grounded in this paper and cite their sources.
H. hircinum attenuated DOX cardiotoxicity in rats; hypothesis-generating and should not change clinical practice.
Oxidative stress is the main factor in doxorubicin (DOX) induced cardiotoxicity. Wistar rats received either DOX (3 mg kg⁻¹, i.p.) every other day or combination of Hypericum hircinum (100 and 200 mg kg⁻¹, p.o.) and DOX or H. hircinum (200 mg kg⁻¹, p.o.) extract alone for 2 weeks. Cardiotoxicity was assessed by recording changes in ECG, heart rate and measuring the levels of cardiac marker enzymes--lactic acid dehydrogenase, creatine phosphokinase, glutamic oxaloacetic transaminase, the antioxidant defence enzymes--reduced glutathione (GSH), superoxide dismutase (SOD) and lipid peroxidative value (LPO) at the end of treatment schedule. Treatment with H. hircinum significantly (p < 0.05) decreased the levels of LPO and marker enzymes, increased the levels of GSH and SOD, reversed the changes in ECG and prevented the decrease in heart weight in DOX-treated group. The results suggest that H. hircinum has the potential to prevent the cardiotoxic effects induced by DOX.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: